While gaining weight after GLP-1 is a possibility, its not definite
Clinical trials have revealed that retatrutide can reduce markers of inflammation, such as C-reactive protein (CRP), which are associated with an increased risk of cardiovascular disease
The packaging should include ice packs or cold inserts
Loss of Active Ingredients Exposure to temperatures outside the recommended range may cause certain active ingredients to break down, impacting the overall stability of the medication
Who Should Exercise Extra Caution or Avoid Retatrutide Patients with a history of medullary thyroid carcinoma, MEN2, pancreatitis, severe gastroparesis, or pregnancy should exercise particular caution or avoid retatrutide until further safety data are available
Reducing side effects through tailored treatment advice (e.g., meal composition and timing) Preventing muscle loss through ensuring adequate protein consumption and resistance training Ensuring sufficient nutrient intake to prevent risk for malnutrition (e.g., incorporating foods rich in B12, calcium, etc.) Building sustainable eating habits focused on maintaining satiety with nutrient-dense meals Nourish GLP-1 Off Ramp Program This pathway is designed for patients who are in the process of discontinuing or have recently discontinued medication